deaths from tirzepatide In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://t.co/4BWhSd0ZCC For Obesity and HFpEF, Tirzepatide

Our data show that in our experimental periodontitis model ( i.e

Common side effects can include nausea, vomiting, and diarrhea, but most individuals tolerate the medication well

CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys

NOX-4 has been found to be involved in inflammation in diabetes and its deletion resulted in the downregulation of Nuclear factor-kappa B (NF-B) signaling, an important mediator of inflammation (Jha et al

C., & Reichenberg, J

Sezgin-Bayindir Z, Losada-Barreiro S, Fernndez-Bravo S, Bravo-Daz C